Freedom Investment Management’s Aegerion Pharmaceuticals AEGR Stock Holding History

Freedom Investment Management’s Portfolio AEGR Stock Details AEGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-84,632	Closed	-$251K	–	1095
2016 Q3	$251K	Sell	84,632 -2,826	-3%	-$4.9K	0.02%	720
2016 Q2	$130K	Buy	87,458 +3,255	+4%	+$7.45K	0.01%	804
2016 Q1	$312K	Buy	84,203 +50,184	+148%	+$311K	0.02%	541
2015 Q4	$344K	Buy	34,019 +1,094	+3%	+$13.2K	0.03%	514
2015 Q3	$866K	Buy	32,925 +10,514	+47%	+$187K	0.09%	190
2015 Q2	$425K	Buy	22,411 +6,474	+41%	+$140K	0.04%	394
2015 Q1	$417K	Buy	+15,937	New	+$406K	0.05%	371

Freedom Investment Management's AEGR Position: Q4 2016 in Review

Freedom Investment Management sold out of Aegerion Pharmaceuticals (AEGR) in Q4 2016, closing a stake of 84,632 shares — an estimated $251K sold.

Freedom Investment Management first reported a position in AEGR in Q1 2015 and held it in 7 quarters. The position peaked at $866K in Q3 2015. 0 funds tracked by Wall St. Rank hold AEGR as of Q4 2016.

Freedom Investment Management reported no remaining Aegerion Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Freedom Investment Management sold 84,632 Aegerion Pharmaceuticals shares in Q4 2016, an estimated $251K.
Freedom Investment Management first reported a position in Aegerion Pharmaceuticals in Q1 2015 and held it in 7 quarters.
Freedom Investment Management's Aegerion Pharmaceuticals position peaked at $866K in Q3 2015.
0 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q4 2016.

Based on Freedom Investment Management's 13F filing for Q4 2016, filed 5 Jan 2017.